ClinicalTrials.Veeva

Menu

Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients

Mass General Brigham logo

Mass General Brigham

Status

Unknown

Conditions

Colonic Neoplasms

Treatments

Behavioral: Behavioral Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01586416
1R03CA157200-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to develop and pilot test a behavioral intervention for elderly adults in treatment for colon cancer, to enhance their skills for managing the challenges of completing chemotherapy regimens. The investigators will assess feasibility and acceptability of the intervention, and explore preliminary efficacy of the intervention for reducing psychological distress and improving rates of optimal chemotherapy adherence.

Enrollment

15 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 60 or older
  • Verbal fluency in English
  • Diagnosis of colon cancer
  • Scheduled to initiate chemotherapy treatment for colon cancer

Exclusion criteria

  • Active, unstable, untreated serious mental illness interfering with ability to participate
  • Cognitive impairment interfering with ability to participate
  • Receiving radiotherapy concomitant with chemotherapy

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Behavioral Intervention
Experimental group
Description:
Brief behavioral intervention on 2-3 sessions of tailored cognitive-behavioral therapy to support chemotherapy adherence and well-being of patients completing chemotherapy for colon cancer.
Treatment:
Behavioral: Behavioral Intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems